Supercharge Your Innovation With Domain-Expert AI Agents!

Progesterone self-emulsifying composition and application

A progesterone and composition technology, applied in the field of progesterone self-emulsifying composition, can solve the problems of low dissolution rate and low bioavailability, and achieve the effects of improving dissolution, good chemical stability and reducing side effects

Inactive Publication Date: 2020-08-14
杭州同惠医药科技有限公司 +1
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] The purpose of the present invention is to provide a self-emulsifying composition of progesterone, which is suitable for commercial progesterone non-injection formulations, in view of the defects of low dissolution rate and low bioavailability in the non-injection formulations of progesterone currently available in the market. While improving the bioavailability of progesterone, it also has a progesterone self-emulsifying preparation composition with good physical and chemical stability. The self-emulsifying composition is composed of a progesterone raw material drug completely dissolved in an oily solvent, a solubilizer and a cosolvent While achieving the purpose of improving the dissolution rate and bioavailability of progesterone in emulsion droplets, the self-emulsifying composition has good long-term physical and chemical stability and is suitable for commercial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Progesterone self-emulsifying composition and application
  • Progesterone self-emulsifying composition and application
  • Progesterone self-emulsifying composition and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Embodiment 1: progesterone self-emulsifying composition

[0024] (1) Progesterone self-emulsifying composition weight composition: 1 part of progesterone, 15 parts of ethyl oleate, 75 parts of vitamin E polyethylene glycol succinate, 1.17 parts of stabilizer, wherein the stabilizer consists of benzyl alcohol, sodium sulfite, Disodium edetate is composed of 10:0.7:1 by mass ratio.

[0025] (2) Preparation of progesterone self-emulsifying composition:

[0026] According to the formula quantity, weigh 10.00 g of benzyl alcohol, 150.00 g of ethyl oleate, and 750.00 g of vitamin E polyethylene glycol succinate, put them in a beaker, stir and mix evenly in a 60°C water bath. Weigh 10.00 g of progesterone and add it to the above solution, then add 0.70 g of sodium sulfite and 1.00 g of disodium edetate, and stir evenly to obtain 921.70 g of progesterone self-emulsifying composition with a drug content of 1.1%.

[0027] (3) Stability test of progesterone self-emulsifying comp...

Embodiment 2

[0031] Embodiment 2: progesterone self-emulsifying composition

[0032] (1) The weight composition of progesterone self-emulsifying composition: 1 part of progesterone, 15 parts of oleic acid, 75 parts of vitamin E polyethylene glycol succinate, 1.17 parts of stabilizer, wherein the stabilizer consists of benzyl alcohol, sodium sulfite, ethylene glycol Disodium amine tetraacetate is composed at a mass ratio of 10:0.7:1.

[0033] (2) Preparation of progesterone self-emulsifying composition:

[0034] According to the formula quantity, weigh 10.00 g of benzyl alcohol, 150.00 g of oleic acid, and 750.00 g of vitamin E polyethylene glycol succinate, put them in a beaker, stir and mix evenly in a water bath at 60°C. Weigh 10.00 g of progesterone and add it to the above solution, stir evenly, then add 0.70 g of sodium sulfite and 1.00 g of disodium ethylenediaminetetraacetate, and stir evenly to obtain 921.70 g of progesterone self-emulsifying composition with a drug content of 1.1% ...

Embodiment 3

[0037] Embodiment 3: progesterone self-emulsifying granule

[0038] 1. Progesterone self-emulsifying composition

[0039] (1) The weight composition of progesterone self-emulsifying composition: 1 part of progesterone, 2 parts of ethyl oleate, 6 parts of vitamin E polyethylene glycol succinate, 1.17 parts of stabilizer, wherein the stabilizer consists of benzyl alcohol, sodium sulfite, Disodium edetate is composed of 10:0.7:1 by mass ratio.

[0040] (2) Preparation of progesterone self-emulsifying composition:

[0041] According to the formula quantity, weigh 10.00 g of benzyl alcohol, 20.00 g of ethyl oleate, and 60.00 g of vitamin E polyethylene glycol succinate, put them in a beaker, stir and mix evenly in a 60°C water bath. Weigh 10.00 g of progesterone and add to the above solution, then add 0.70 g of sodium sulfite and 1.00 g of disodium ethylenediamine tetraacetate, and stir evenly to obtain 101.70 g of progesterone self-emulsifying composition.

[0042] 2. Progester...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Specific surface areaaaaaaaaaaa
Particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention discloses a progesterone self-emulsifying composition and an application. The progesterone self-emulsifying composition is prepared from the raw materials in parts by mass of 1 part of progesterone, 2-15 parts of solvent, 6-75 parts of vitamin E polyethylene glycol succinate and 0.5-2 parts of stabilizer. The solvent is oleic acid or ethyl oleate; and the stabilizer is one or a mixture of several of benzyl alcohol, sodium sulfite and ethylenediamine tetraacetic acid disodium salt in any proportion. The progesterone preparation composition disclosed by the invention is high in chemical stability, an acceleration experiment is carried out according to the requirements of acceleration experiments in four stability experiments in Chinese Pharmacopoeia 2015 edition, single impurities do not exceed 0.5% at the end point of 6 months, the total impurity mass does not exceed 2.0%, the content is 93%-107%, the progesterone injection meets the requirements of progesterone injectionin Chinese Pharmacopoeia 2015 edition on content and impurity acceptance standards, and is high in product stability and suitable for commercial production.

Description

[0001] (1) Technical field [0002] The invention relates to a progesterone self-emulsifying composition and its application. [0003] (2) Background technology [0004] Progesterone, also known as progesterone, is the main biologically active progesterone secreted by the ovary. Progesterone is widely used in the treatment of menstrual disorders, such as amenorrhea, dysfunctional uterine bleeding, corpus luteum insufficiency, threatened miscarriage and habitual miscarriage, premenstrual tension syndrome, menopausal syndrome, etc. However, progesterone is a steroid hormone with low solubility, so it is poorly absorbed in the body after oral administration, and is easily metabolized and inactivated by the liver. These factors lead to low bioavailability of progesterone in the human body. degree is only about 10%. The unabsorbed progesterone is mainly metabolized by the liver, which causes great damage to the liver. However, the progesterone injection is highly irritating durin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/107A61K31/57A61K47/12A61K47/14A61K47/22A61K47/10A61K47/02A61K47/18A61P15/00A61P7/04A61P15/06A61P15/12
CPCA61K9/1075A61K31/57A61K47/02A61K47/10A61K47/12A61K47/14A61K47/183A61K47/22A61P7/04A61P15/00A61P15/06A61P15/12
Inventor 沈志群董永峰沈家林傅恩军
Owner 杭州同惠医药科技有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More